List of Figures
Figure 1: Direct to Consumer Advertising in Pharmaceuticals, DTC Spend by Therapeutic Class,%, 2011
Figure 2: Direct to Consumer Advertising in Pharmaceuticals, Total Promotional Spending on Prescription Drugs, $bn, 1996–2011
Figure 3: Direct to Consumer Advertising in Pharmaceuticals , DTC Average Budget Allocation, DTC Expenditure on Top Three Media Types, %, 2010
Figure 4: Direct to Consumer Advertising in Pharmaceuticals, FDA Guidelines on DTC Marketing of Pharmaceuticals, 2009
Figure 5: Direct to Consumer Advertising in Pharmaceuticals, Factors Influencing Decrease in DTC Spending, 2007–2011
Figure 6: Direct to Consumer Advertising in Pharmaceuticals, Proliferation of Brand Message Through Word of Mouth
Figure 7: Direct to Consumer Advertising in Pharmaceuticals, Top 10 Most Visited Social Network Sites in the US, 2011
Figure 8: Direct to Consumer Advertising in Pharmaceuticals, Twitter Account Information – 15 Major Pharmaceutical Users
Figure 9: Direct to Consumer Advertising in Pharmaceuticals, Most Commonly Tweeted Topic for Pharmaceutical Accounts
Figure 10: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics – AstraZeneca’s Tweet Chat, 2011
Figure 11: Direct to Consumer Advertising in Pharmaceuticals, AstraZeneca, Consumer Sentiment During Twitter Chat, 2011
Figure 12: Direct to Consumer Advertising in Pharmaceuticals, Tweet Topics – Shire’s @ADHDSupport
Figure 13: Direct to Consumer Advertising in Pharmaceuticals, Types of YouTube Advertisement
Figure 14: Direct to Consumer Advertising in Pharmaceuticals, Campaign Reach
Figure 15: Direct to Consumer Advertising in Pharmaceuticals, Campaign Engagement
Figure 16: Direct to Consumer Advertising in Pharmaceuticals, Campaign Attention
Figure 17: Direct to Consumer Advertising in Pharmaceuticals, Campaign Positive Sentiment, %
Figure 18: Direct to Consumer Advertising in Pharmaceuticals, Social Media Promotion to Prescription
Figure 19: Direct to Consumer Advertising in Pharmaceuticals, Factors for Budget Allocation and Media Mix
Figure 20: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change of National Health Expenditure, 1970–2010
Figure 21: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Company, $m, 2011
Figure 22: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Company, 2010 – 2011
Figure 23: Direct to Consumer Advertising in Pharmaceuticals, US DTC Spend by Brand, $m, 2011
Figure 24: Direct to Consumer Advertising in Pharmaceuticals, Percentage Change in US DTC Spend by Brand, 2010–2011
Figure 25: Direct to Consumer Advertising in Pharmaceuticals, Team Copaxone Campaign – Regulation Breaching Statements
Figure 26: Royal Pharmaceutical Society of Great Britain on EU Proposal to Allow Restricted Branded DTC Advertising